Clofibrate and niacin in coronary heart disease.
D000328:Adult; D001157:Arterial Occlusive Diseases / Q000150:complications; D002561:Cerebrovascular Disorders / Q000150:complications; D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D004562:Electrocardiography; D005500:Follow-Up Studies; D006333:Heart Failure / Q000150:complications; D006801:Humans; D007383:Intermittent Claudication / Q000150:complications; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010919:Placebos; D013997:Time Factors; D014280:Triglycerides / Q000097:blood*
D009539:Nicotinic Acids; D010919:Placebos; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate